10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 267 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $427,336 | -38.0% | 21,971 | +19.6% | 0.00% | -50.0% |
| Q1 2024 | $689,351 | -36.2% | 18,368 | -4.9% | 0.00% | -50.0% |
| Q4 2023 | $1,080,923 | +26.1% | 19,316 | -7.0% | 0.00% | 0.0% |
| Q3 2023 | $857,051 | -16.4% | 20,777 | +13.2% | 0.00% | -20.0% |
| Q2 2023 | $1,025,111 | +15.1% | 18,358 | +15.0% | 0.01% | +25.0% |
| Q1 2023 | $890,799 | +53.3% | 15,967 | +0.1% | 0.00% | +33.3% |
| Q4 2022 | $581,218 | +46.8% | 15,950 | +14.8% | 0.00% | +50.0% |
| Q3 2022 | $396,000 | -37.9% | 13,890 | -1.6% | 0.00% | -50.0% |
| Q2 2022 | $638,000 | -44.3% | 14,110 | -6.3% | 0.00% | -33.3% |
| Q1 2022 | $1,145,000 | -42.3% | 15,051 | +13.0% | 0.01% | -40.0% |
| Q4 2021 | $1,984,000 | +2.5% | 13,319 | +0.1% | 0.01% | 0.0% |
| Q3 2021 | $1,936,000 | -33.4% | 13,301 | -10.4% | 0.01% | -37.5% |
| Q2 2021 | $2,906,000 | -38.9% | 14,839 | -43.5% | 0.02% | -42.9% |
| Q1 2021 | $4,757,000 | +6.0% | 26,282 | -17.0% | 0.03% | +3.7% |
| Q4 2020 | $4,486,000 | – | 31,684 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 2,106,757 | $117,894,122 | 100.00% |
| Blue Water Life Science Advisors, LP | 194,500 | $10,884,220 | 9.53% |
| Sands Capital Ventures, LLC | 481,770 | $26,959,849 | 7.50% |
| Meritech Capital Associates V L.L.C. | 494,236 | $27,657,447 | 6.73% |
| Decheng Capital LLC | 359,554 | $20,120,642 | 5.62% |
| Iron Triangle Partners LP | 479,374 | $26,825,769 | 3.47% |
| Brown Capital Management | 3,527,297 | $197,387,540 | 2.96% |
| Freshford Capital Management, LLC | 305,798 | $17,112,456 | 2.78% |
| SVB WEALTH LLC | 1,446,552 | $80,949,066 | 1.97% |
| Capital Impact Advisors, LLC | 23,594 | $1,320,320 | 1.74% |